Targeting leucine-rich repeat kinase 2 in Parkinson's disease

By Chan Sharon L   Angeles Dario C   Tan Eng-King  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1471-1482

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 927-938

Bentham Science Publishers

Access to resources Recommend Favorite

Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011)

By Deng Xianming   Choi Hwan Geun   Buhrlage Sara J.   Gray Nathanael S.  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1415-1426

Informa Healthcare

Access to resources Recommend Favorite

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis

By Serada Satoshi   Fujimoto Minoru   Terabe Fumitaka   Iijima Hideki   Shinzaki Shinichiro   Matsuzaki Shinya   Ohkawara Tomoharu   Nezu Riichiro   Nakajima Sachiko   Kobayashi Taku   Plevy Scott Eric   Takehara Tetsuo   Naka Tetsuji  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2169-2179

Blackwell Publishing

Access to resources Recommend Favorite

Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins

By  

Current Cancer Drug Targets, Vol. 16, Iss. 5, 2016-06 ,pp. : 400-414

Bentham Science Publishers

Access to resources Recommend Favorite